As part of a select group of 25 national clinical sites, The Ohio State University Medical Center and Nationwide Children’s Hospital received a seven year grant which supports clinical trials for neurologic diseases.
The National Institute of Health has created a Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) program that fosters the cooperation needed between sites across the country to conduct timely trials. The first meeting of all NeuroNEXT principal investigators will be held on Nov. 18 at the NIH in Bethesda, Maryland.
“The program promises to fundamentally alter how neurologic trials are performed in this country by increasing the efficiency and quality of studies while reducing the costs of trials,” said John Kissel, program director in the Division of Neuromuscular Medicine at Ohio State Medical Center and principal investigator for the project. “The award recognizes the unique and extensive basic, translational and clinical neuroscience research done at Ohio State, and the depth and breadth of experience represented by the neuroscience faculty.”
NeuroNEXT coordinates centers studying the same disease to improve future trials for patients. It allows clinical sites to efficiently design and implement pediatric and adult clinical trials encompassing the entire spectrum of neurologic diseases. Clinical sites will be able to consolidate resources, integrating the efforts and components of experienced neuroscience clinical trial groups more fully into existing initiatives.
The program will build on the comprehensive research through The Ohio State University Center for Clinical and Translational Science, the Department of Neuroscience at the Ohio State College of Medicine, and the Departments of Neurology and Neurological Surgery at Ohio State and Nationwide Children’s. Co-principal investigators involved in the NeuroNEXT program include Dr. Ali Rezai at The Ohio State University Medical Center and Dr. E. Steve Roach at Nationwide Children’s.
Columbus Hospitals Awarded Grant for Neuroscience Trials
October 20, 2011
About Nationwide Children's Hospital
Named to the Top 10 Honor Roll on U.S. News & World Report’s 2023-24 list of “Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit free-standing pediatric health care systems providing unique expertise in pediatric population health, behavioral health, genomics and health equity as the next frontiers in pediatric medicine, leading to best outcomes for the health of the whole child. Integrated clinical and research programs, as well as prioritizing quality and safety, are part of what allows Nationwide Children’s to advance its unique model of care. Nationwide Children’s has a staff of more than 14,000 that provides state-of-the-art wellness, preventive and rehabilitative care and diagnostic treatment during more than 1.7 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded free-standing pediatric research facilities. More information is available at NationwideChildrens.org.